Telmisartan/amlodipine/indapamide

Last updated

Telmisartan/amlodipine/indapamide
Combination of
Telmisartan angiotensin II receptor blocker
Amlodipine dihydropyridine calcium channel blocker
Indapamide thiazide-like diuretic
Clinical data
Trade names Widaplik
AHFS/Drugs.com Widaplik
License data
Pregnancy
category
Routes of
administration 		By mouth
ATC code
  • None
Legal status
Legal status

Telmisartan/amlodipine/indapamide, sold under the brand name Widaplik, is a fixed-dose combination medication used for the treatment of hypertension (high blood pressure). [1] It contains telmisartan, an angiotensin II receptor blocker; amlodipine, as the besilate salt, a dihydropyridine calcium channel blocker; and indapamide, a thiazide-like diuretic. [1] [2]

Contents

The combination telmisartan/amlodipine/indapamide was approved for medical use in the United States in June 2025. [1]

Medical uses

Telmisartan/amlodipine/indapamide is indicated for the treatment of hypertension. [1]

Society and culture

The combination telmisartan/amlodipine/indapamide was approved for medical use in the United States in June 2025. [1]

References

  1. 1 2 3 4 5 6 "Widaplik (telmisartan, amlodipine and indapamide) tablets, for oral use" (PDF). George Medicines. 2025. Retrieved 9 June 2025.
  2. ↑ Satheesh GS, Dhurjati R, Salam A, Moran AE, Murphy A, Perel P, et al. (2025). Triple fixed-dose combination antihypertensive therapy (PDF) (Report). World Health Organization. Retrieved 9 June 2025.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.